Evidence map›Paper›PMID 40238458›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Regulatory mimicry of cyclin-dependent kinases by a conserved herpesvirus protein kinase.

Naoto Koyanagi, Kowit Hengphasatporn, Akihisa Kato, Moeka Nobe, Kosuke Takeshima, Yuhei Maruzuru, Katsumi Maenaka, Yasuteru Shigeta, Yasushi Kawaguchi

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Naoto KoyanagiDivision of Molecular Virology, Department of Microbiology and Immunology, the Institute of Medical Science, The University of Tokyo, Minato-ku 108-8639, Tokyo, Japan.
Kowit HengphasatpornCenter for Computational Sciences, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
Akihisa KatoDivision of Molecular Virology, Department of Microbiology and Immunology, the Institute of Medical Science, The University of Tokyo, Minato-ku 108-8639, Tokyo, Japan.
Moeka NobeDivision of Molecular Virology, Department of Microbiology and Immunology, the Institute of Medical Science, The University of Tokyo, Minato-ku 108-8639, Tokyo, Japan.
Kosuke TakeshimaDivision of Molecular Virology, Department of Microbiology and Immunology, the Institute of Medical Science, The University of Tokyo, Minato-ku 108-8639, Tokyo, Japan.
Yuhei MaruzuruDivision of Molecular Virology, Department of Microbiology and Immunology, the Institute of Medical Science, The University of Tokyo, Minato-ku 108-8639, Tokyo, Japan.
Katsumi MaenakaCenter for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku 060-0812, Sapporo, Japan.ORCID 0000-0002-5459-521X
Yasuteru ShigetaCenter for Computational Sciences, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
Yasushi KawaguchiDivision of Molecular Virology, Department of Microbiology and Immunology, the Institute of Medical Science, The University of Tokyo, Minato-ku 108-8639, Tokyo, Japan.ORCID 0000-0001-8232-6925

Funding

Japan Agency for Medical Research and Development (AMED) JP20wm0125002Japan Agency for Medical Research and Development (AMED) JP223fa627001Japan Agency for Medical Research and Development (AMED) JP22fk0108640Japan Agency for Medical Research and Development (AMED) JP22gm1610008Japan Agency for Medical Research and Development (AMED) JP23wm0225031Japan Agency for Medical Research and Development (AMED) JP23wm0225035MEXT | Japan Science and Technology Agency (JST) JPMJPR22R5MEXT | Japan Society for the Promotion of Science (JSPS) 20H05692Ministry of Education, Culture, Sports, Science and Technology (MEXT) 21H00338Ministry of Education, Culture, Sports, Science and Technology (MEXT) 21H00417Ministry of Education, Culture, Sports, Science and Technology (MEXT) 22H04803Ministry of Education, Culture, Sports, Science and Technology (MEXT) 22H05584
6 · The paper itself

Abstract

Herpesviruses encode conserved protein kinases (CHPKs) that target cellular cyclin-dependent kinase (CDK) phosphorylation sites; thus, they are termed viral CDK-like kinases. Tyrosine 15 in the GxGxxG motifs of CDK1 and CDK2, whose phosphorylation down-regulates their catalytic activities, is conserved in the corresponding motifs of CHPKs. We found that CHPK UL13, the corresponding Tyr-162 in herpes simplex virus 2 (HSV-2), was phosphorylated in HSV-2-infected cells. Mutational analyses of HSV-2 UL13 Tyr-162 suggested that phosphorylation of UL13 Tyr-162 reduced the phosphorylation of all UL13 substrates tested in HSV-2-infected cells. These findings suggested that HSV-2 UL13 mimicked the regulatory mechanism of CDKs and that this CHPK has regulatory and functional mimicry with CDKs. Furthermore, phosphorylation of HSV-2 UL13 Tyr-162 was suggested to be required for the downregulation of viral replication and pathogenicity, specifically in the brains of mice, and for efficient viral recurrence in guinea pigs. These findings highlight the dual impact of the regulatory mimicry of CDKs by CHPK on the fine-tuned regulation of lytic and latent HSV-2 infections in vivo.

Indexed as

Cyclin-Dependent KinasesHerpesvirus 2, HumanMolecular MimicryProtein KinasesViral ProteinsAnimalsChlorocebus aethiopsGuinea PigsHumansMicePhosphorylationVirus ReplicationCyclin-Dependent KinasesProtein KinasesUL13 protein, SimplexvirusViral ProteinsCDKsCHPKHSVmimicphosphorylation

Identifiers

PMID40238458
PMCPMC12037052

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.